Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT204 | Individual Protein | Acetylcholinesterase | Homo sapiens | Activity | = | 93 | % | DrugMatrix in vivo data: Pathology |
NPT450 | Organism | Meloidogyne incognita | Meloidogyne incognita | EC50 | > | 250 | ug/ml | 20949916 |
NPT2 | Others | Unspecified | Ratio CC50/IC50 | = | 1.59 | 20958014 | ||
NPT963 | Organism | Hepatitis B virus | Hepatitis B virus | IC50 | = | 353560 | nM | 22342628 |
NPT450 | Organism | Meloidogyne incognita | Meloidogyne incognita | EC50 | > | 250 | ug/ml | 17850214 |
NPT963 | Organism | Hepatitis B virus | Hepatitis B virus | IC50 | = | 431230 | nM | 11473426 |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Activity | = | 58.6 | % | 17988094 |
NPT65 | Cell Line | HepG2 | Homo sapiens | CC50 | = | 562190 | nM | Open TG-GATES in vivo data: Organ Weight |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Activity | = | 8.02 | % | DrugMatrix in vivo data: Biochemistry |
NPT2 | Others | Unspecified | Ratio CC50/IC50 | = | 1.3 | 19368377 | ||
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Inhibition | = | 61 | % | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC471376 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.7667 | Intermediate Similarity | NPC166487 |
0.7625 | Intermediate Similarity | NPC470796 |
0.7419 | Intermediate Similarity | NPC300455 |
0.7284 | Intermediate Similarity | NPC105991 |
0.7073 | Intermediate Similarity | NPC470795 |
0.6629 | Remote Similarity | NPC8981 |
0.6556 | Remote Similarity | NPC195713 |
0.6522 | Remote Similarity | NPC471895 |
0.6522 | Remote Similarity | NPC307163 |
0.6517 | Remote Similarity | NPC299367 |
0.6449 | Remote Similarity | NPC190955 |
0.6436 | Remote Similarity | NPC120203 |
0.6395 | Remote Similarity | NPC125144 |
0.6395 | Remote Similarity | NPC121708 |
0.6311 | Remote Similarity | NPC11466 |
0.617 | Remote Similarity | NPC472169 |
0.6133 | Remote Similarity | NPC108375 |
0.6105 | Remote Similarity | NPC470794 |
0.6061 | Remote Similarity | NPC470797 |
0.596 | Remote Similarity | NPC2751 |
0.5952 | Remote Similarity | NPC22627 |
0.5823 | Remote Similarity | NPC476214 |
0.5816 | Remote Similarity | NPC148231 |
0.5769 | Remote Similarity | NPC175376 |
0.5648 | Remote Similarity | NPC173019 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC471376 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.6907 | Remote Similarity | NPD532 | Approved |
0.6699 | Remote Similarity | NPD745 | Clinical (unspecified phase) |
0.6635 | Remote Similarity | NPD183 | Approved |
0.6505 | Remote Similarity | NPD793 | Approved |
0.6337 | Remote Similarity | NPD1672 | Phase 2 |
0.6262 | Remote Similarity | NPD445 | Discontinued |
0.6053 | Remote Similarity | NPD3907 | Clinical (unspecified phase) |
0.6019 | Remote Similarity | NPD9702 | Discontinued |
0.6 | Remote Similarity | NPD9356 | Discontinued |
0.5966 | Remote Similarity | NPD5702 | Clinical (unspecified phase) |
0.5872 | Remote Similarity | NPD3459 | Approved |
0.5826 | Remote Similarity | NPD1944 | Phase 2 |
0.5766 | Remote Similarity | NPD2242 | Phase 1 |
0.5678 | Remote Similarity | NPD483 | Approved |
PubChem CID   | 6876527 |
ChEMBL   | CHEMBL2420347 |
ZINC   |
Molecular Weight:   | 127.01 |
ALogP:   | 0.4401 |
MLogP:   | 1.68 |
XLogP:   | 2.013 |
# Rotatable Bonds:   | 2 |
Polar Surface Area:   | 60.83 |
# H-Bond Aceptor:   | 0 |
# H-Bond Donor:   | 1 |
# Rings:   | 1 |
# Heavy Atoms:   | 8 |